Drug Topics

OCTOBER 10, 2024

Researchers analyzed the potential role of nonphysician health care providers to provide vaccine services outside of traditional health care settings.

Vaccines 198

Vaccines 198

STAT

OCTOBER 10, 2024

Nearly 60% of the experts who reviewed manuscripts for four prominent medical journals received at least one payment from industry during a recent three-year period and, overall, these reviewers or their institutions received more than $1 billion from companies, according to a new analysis. Between 2020 and 2022, 1,155 of the 1,962 experts who reviewed studies for The BMJ, JAMA, The Lancet, and The New England Journal of Medicine received some form of payment.

137

137

Fierce Healthcare

OCTOBER 10, 2024

Just 40% of Medicare Advantage prescription drug plans offered in 2025 achieved a score of four stars or higher, the Centers for Medicare & Medicaid Services (CMS) revealed Oct. 10. | It's harder than ever for Medicare Advantage plans to score well on star ratings. Here's how they performed for 2025.

125

125

STAT

OCTOBER 10, 2024

Bill Nye the Science Guy is temporarily rebranding. For now, he’s “ Bill Nye the Ataxia Advocate Guy ,” as he aims to bring awareness to a neurological disease that has affected his family for generations. Nye has previously spoken about the genetic disease, which makes it difficult for people with the condition to control their muscles and often leads to problems with walking and speech, in a documentary released in 2017.

126

126

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

OCTOBER 10, 2024

Suki, a voice-assistive AI and medical scribe tool, secured $70 million in fresh funding to build out its AI assistant technology for doctors and hospitals. | Suki, a voice-assistive AI and medical scribe tool, secured $70 million in fresh funding to build out its AI assistant technology for doctors and hospitals.

Hospitals 120

Hospitals 120

pharmaphorum

OCTOBER 10, 2024

Media personality Nadia Sawalha is heading a fundraising effort to launch an appeal against NICE's recent rejection of a breast cancer therapy Enhertu.

115

115

STAT

OCTOBER 10, 2024

Telehealth providers treating opioid use disorder, ADHD, and women’s health issues say the sector is in a state of frustration and chaos as the pandemic-era flexibilities that allowed their businesses to thrive are set to end with no new rules in sight. With just months to go before the ability to prescribe controlled substances online dramatically changes overnight, the vacuum of information is forcing them to devote significant energy preparing for the unknown.

Controlled Substances 112

Controlled Substances Patient Care 112

Pharmacy Times

OCTOBER 10, 2024

Although the findings indicate a potential for predicting asthma or wheezing onset, these trends cannot yet be used for early diagnoses in individual children.

111

111

STAT

OCTOBER 10, 2024

On Thursday, the CDC released new data showing that almost 15.5 million U.S. adults are living with ADHD. More than half of those individuals received their diagnosis in adulthood.   That includes me. The diagnosis came as a relief and validation — a way to understand years of impulsivity, inattention, and struggles with daily life. I was diagnosed at age 36, after first one, then two, and ultimately, four of my five children were also diagnosed with ADHD.

111

111

pharmaphorum

OCTOBER 10, 2024

Starboard Value alleges former Pfizer execs Ian Read and Frank D'Amelio were bullied into lending their support to current management

110

110

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

OCTOBER 10, 2024

Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting zbecker Thu, 10/10/2024 - 11:03

109

109

pharmaphorum

OCTOBER 10, 2024

EVERSANA partners Oracle on pharmacovigilance platform Phil.

110

110

STAT

OCTOBER 10, 2024

Amid excitement over everything from Chat-GPT to Nobel Prize-winning chemistry research that uses artificial intelligence to predict protein structures, academics Aravind Narayan and Sayash Kapoor have established a reputation for throwing cold water on at least some of the claims about how AI will transform people’s lives.  Narayan, a professor of computer science at Princeton University, went viral in 2019 for a talk he gave at MIT on how to recognize overblown declarations about A

Hospitals 108

Hospitals 108

Pharmacy Times

OCTOBER 10, 2024

Knowing the benefits and effects of norgestrel can assist pharmacists when counseling patients.

108

108

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

BioPharm

OCTOBER 10, 2024

Solving the challenge of better-stabilized temperature-sensitive biomolecules hinges on innovative formulation strategies.

105

105

The Checkup by Singlecare

OCTOBER 10, 2024

Capsaicin is a natural compound found in capsicum, or peppers. It’s responsible for giving jalapeños, cayenne peppers, and other hot peppers their signature heat. For many years, capsaicin has been extracted from peppers and used as a natural remedy for pain , according to the National Institutes of Health (NIH). Capsaicin in chili peppers is also known to have antioxidant effects , which help protect against disease. “ Capsaicin has been recognized for its numerous health benefits, including pr

Compounding 105

Compounding Dosage FDA 105

Pharmacy Times

OCTOBER 10, 2024

The FDA also approved the FoundationOne Liquid CDx assay as a companion diagnostic device to identify patients who would benefit from the treatment.

FDA 104

FDA 104

Fierce Pharma

OCTOBER 10, 2024

As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a 2-billion-Swiss-francs luster to the once high-flying portfolio. | As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a 2-billion-Swiss-francs luster to the once high-flying portfolio.

FDA 103

FDA 103

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Outsourcing Pharma

OCTOBER 10, 2024

The big pharma company AstraZeneca has forged a licensing pact worth $2 billion with the Chinese firm CSPC Pharmaceutical Group for access to an experimental small molecule treatment for dyslipidemia.

103

103

pharmaphorum

OCTOBER 10, 2024

AI and new technologies: How the pharmaceutical industry is reinventing itself to meet ever more urgent needs Mike.

103

103

Fierce Healthcare

OCTOBER 10, 2024

Intravenous fluid shortages appear to be affecting the majority of the nation’s healthcare providers, who as a result are already beginning to cancel procedures, survey data published Thursday show | Premier said 86% of its provider members are reporting shortages, and more than half have less than 10 days supply on hand. Respondents also said they were beginning or considering procedure cancellations, and have begun receiving solicitations from "unapproved, gray market suppliers.

131

131

pharmaphorum

OCTOBER 10, 2024

Ono Pharma and Boehringer Ingelheim both added to their cancer pipelines, licensing drugs from LigaChem Bio and Circle Pharma, respectively.Ono's deal with South Korean antibody-drug conjugate (ADC) specialist LigaChem is worth up to $700 million and covers a license to a preclinical-stage candidate for solid tumours, as well as an R&D collaboration to seek out other ADC candidates.

102

102

STAT

OCTOBER 10, 2024

The director general of the Africa Centres for Disease Control and Prevention and Rwanda’s health minister on Thursday criticized the U.S. government’s decision to urge Americans to avoid travel to Rwanda because of the country’s ongoing Marburg outbreak. Calling the travel alert a travel ban — it is not — Jean Kaseya, who heads the Africa CDC, suggested the U.S. action was counterproductive and unfair to a country that is being transparent about its efforts to

99

99

European Pharmaceutical Review

OCTOBER 10, 2024

A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). This is updated strategy replaces the original five-year strategy, which was developed to cover from 2021 to 2025 (EMANS 2025). Revised strategy – adapting to change The draft strategy covers the following focus areas up to 2028: Accessibility to support pathways for medicine access in the EU Leveraging data, digitalisation and artificial intelligen

98

98

Hospital Pharmacy Europe

OCTOBER 10, 2024

Katie Joyce and colleagues describe how their hospital pharmacy team in the north of England worked collaboratively across the primary-secondary care interface to implement shared care agreements for a cohort of 270 patients prescribed amiodarone to optimise the patient experience, overcome operational challenges and streamline processes. Amiodarone is a class III antiarrhythmic drug used both in the acute and long-term management of cardiac rhythm disorders.

Hospitals 98

Hospitals Medical Records Patient Care 98

Outsourcing Pharma

OCTOBER 10, 2024

Evaxionâs proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer vaccine targets.

Vaccines 95

Vaccines 95

Drug Topics

OCTOBER 10, 2024

Additional research is needed to determine if the therapy can help with cognitive symptoms of post–COVID-19 condition.

94

94

STAT

OCTOBER 10, 2024

The ink had scarcely dried on  new federal rules  for enforcement of the Mental Health Parity and Addiction Equity Act of 2008 when U.S. health plans  threatened potential legal action  to block them.  Buoyed by a recent Supreme Court ruling that  shifts power away from federal agencies , health plans apparently hope to keep the departments of Labor, Treasury, and Health and Human Services from making parity a reality, years after Congress passed the law with r

94

94

pharmaphorum

OCTOBER 10, 2024

To succeed, medical start-ups must navigate the evolving risks associated with the FDA's final rule. Learn how to effectively address these challenges and ensure compliance.

FDA 93

FDA 93

Pharmacy Times

OCTOBER 10, 2024

A single dose RSV vaccine per year can offer optimal protection against 3 full RSV seasons.

Vaccines 92

Vaccines 92

STAT

OCTOBER 10, 2024

U.S. Sen. Elizabeth Warren has asked the Federal Trade Commission “closely scrutinize” a $16.5 billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading contract drug manufacturer, over concerns the acquisition would give the pharmaceutical company an unfair advantage in the burgeoning market for drugs used to treat obesity and diabetes.

Packaging 92

Packaging Pharmaceutical Companies Pharmaceutical Companies 92

Fierce Pharma

OCTOBER 10, 2024

As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. | In a letter to the chair of the U.S. Federal Trade Commission, Lina Khan, Sen. Elizabeth Warren is calling on the antitrust agency to “carefully scrutinize” Novo Holding’s multibillion-dollar bid for CDMO Catalent.

89

89

STAT

OCTOBER 10, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Morning. Today, we are sad to report that more children have developed blood cancers after receiving Bluebird Bio’s CALD gene therapy, Skysona. There’s a new twist in the Pfizer activist shareholder campaign.

90

90